Molecular Imaging News and Research

RSS

Nuclear medicine imaging assesses melanoma patients' response to immunotherapy

Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this way, a patient's therapy can be more effectively tailored to his or her personal response.

6 Mar 2019

MR Solutions to showcase latest multi-modality MRI systems at EMIM 2019

MR Solutions’ latest compact preclinical, multi-modality MRI systems will be on display at the 14th European Molecular Imaging Meeting (EMIM 2019) being held at the Scottish Event Campus in Glasgow on 19 to 22 March, 2019.

From MR Solutions 28 Feb 2019

RWTH Aachen chooses MILabs’ hybrid OI/CT system to enhance molecular imaging research

RWTH Aachen University have chosen the MILabs high-resolution CT to further enhance its world-leading molecular imaging research.

26 Feb 2019

New PET/CT tracer shows high detection rate for diagnosis of acute venous thromboembolism

A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism.

18 Feb 2019

Artificial intelligence can accurately predict prognosis of ovarian cancer patients

The artificial intelligence software, created by researchers at Imperial College London and the University of Melbourne, has been able to predict the prognosis of patients with ovarian cancer more accurately than current methods. It can also predict what treatment would be most effective for patients following diagnosis.

15 Feb 2019

Researchers conduct extensive comparison of drugs used in treating neuroendocrine tumors

An increasing number of new anti-cancer drugs are made available each year. During the authorization process, such new drugs usually undergo comparisons to one, but only rarely to multiple established drugs.

14 Feb 2019

New PET imaging agent may help measure efficacy or failure of hormone therapy for breast cancer

Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine.

12 Feb 2019

SPECT imaging combined with cardiac MRI could help improve ventricular tachycardia ablation

Adding functional imaging to structural imaging of patients with ventricular tachycardia (VT) has the potential to improve current VT ablation strategies, according to new research published in the January issue of The Journal of Nuclear Medicine.

30 Jan 2019

New nuclear medicine method could improve detection of primary and metastatic melanoma

A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma.

18 Jan 2019

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

New research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well as currently used predictive tools to determine the risk for advanced disease.

12 Dec 2018

Avoidant grievers unconsciously monitor and block mind-wandering contents, study shows

People who are grieving a major loss, such as the death of a spouse or a child, use different coping mechanisms to carry on with their lives. Psychologists have been able to track different approaches, which can reflect different clinical outcomes.

11 Dec 2018

Precisely targeted prostate cancer radiotherapy possible with nuclear medicine imaging

Current standard imaging techniques for initial staging of prostate cancer often underestimate the extent of disease beyond the prostate.

9 Nov 2018

Precision medicine: Statistical methods play key role in predicting efficacy of new drugs

The aim of "precision medicine" is to devise individualized treatment strategies and therapies. Statistical methods play an important role in predicting the efficacy of drugs from clinical study data, based on patient characteristics.

8 Nov 2018

New nuclear medicine tracer could improve diagnosis, treatment of non-small cell lung cancer

Researchers have developed a new nuclear medicine tracer that could improve diagnosis and treatment of non-small cell lung cancer.

7 Nov 2018

New AUC published for lumbar puncture and spinal fluid analysis in Alzheimer's diagnosis

In preparation for more tools that detect and measure the biology associated with Alzheimer's and other dementias earlier and with more accuracy, an Alzheimer's Association-led Workgroup has published appropriate use criteria for lumbar puncture (spinal tap) and spinal fluid analysis in the diagnosis of Alzheimer's disease.

10 Oct 2018

Researchers receive $1.2 million grant to test potential treatment for metastatic breast cancer

A team of Medical University of South Carolina Hollings Cancer Center researchers received a three-year, $1.2 million grant from the U.S. Department of Defens to test a potential therapeutic antibody that could block breast cancer growth with fewer side effects, opening up potential for future drug development.

5 Oct 2018

Study shows possibility of using PET imaging to manage chronic liver diseases

While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications. These effects may soon be a thing of the past for some patients thanks to new research showing PET imaging with the 18F-FAC radiotracer can be used as a non-invasive substitute. The study is featured in the October issue of The Journal of Nuclear Medicine.